Olfactory Mucosal Mesenchymal Stem Cell‐Derived Exosomal LncA2M ‐ AS1 Ameliorates Parkinson's Disease by Regulating Microglial Glucose Metabolic Reprogramming and Neuroinflammation via the CFL1 / ROCK1 Axis

CNS Neuroscience & Therapeutics · Published 2026-07-01 · DOI 10.1002/cns.71019

Free full text

Authors (7)

Jiangshan Zhang, Guoshuai Yang, Yanhui Zhou, Dan Hou, Chuang Wang, Yujie Hu, Ying Xia

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, J., Yang, G., Zhou, Y., et al. (2026). Olfactory Mucosal Mesenchymal Stem Cell‐Derived Exosomal LncA2M ‐ AS1 Ameliorates Parkinson's Disease by Regulating Microglial Glucose Metabolic Reprogramming and Neuroinflammation via the CFL1 / ROCK1 Axis. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.71019

Related articles